Search for: "Watson Pharmaceuticals"
Results 101 - 120
of 359
Sort by Relevance
|
Sort by Date
14 Feb 2013, 9:59 pm
By Kevin E. [read post]
6 Feb 2013, 4:43 pm
Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug. [read post]
1 Feb 2013, 10:32 am
Watson Pharmaceuticals. [read post]
15 Jan 2013, 11:33 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
13 Jan 2013, 9:06 pm
.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
9 Jan 2013, 11:01 pm
Watson Pharmaceuticals, Inc., to address whether and when “reverse payment” agreements made to settle ANDA litigation violate antitrust laws. [read post]
7 Jan 2013, 9:02 am
Watson Pharmaceuticals — legality under federal antitrust law of payment by a brand-name drug maker to a maker of a generic counterpart, to delay the generic drug’s market entry (Justice Samuel Alito, Jr., is recused.) [read post]
30 Nov 2012, 12:21 pm
Currently, Ranbaxy is responsible for about 40% of the U.S. market for the popular cholesterol drug; other companies that distribute similar products are Mylan and Watson Pharmaceuticals. [read post]
15 Nov 2012, 7:50 am
Watson of the U.S. [read post]
12 Nov 2012, 4:14 pm
Ortho Pharmaceutical Corp., 615 F. [read post]
31 Oct 2012, 10:31 am
He also represented Watson Pharmaceuticals Inc. in its $5.9 billion purchase of Swiss drug maker Actavis Inc., which was approved by the FTC (with divestitures) earlier in October. [read post]
23 Oct 2012, 6:30 am
Watson Pharmaceuticals, Inc., No. 12-416 (U.S. [read post]
19 Oct 2012, 6:13 pm
For two other drugs, Watson and Actavis would be required to relinquish the marketing rights to another firm.The case is Watson Pharmaceuticals, Inc., FTC Dkt. [read post]
5 Oct 2012, 11:43 am
Watson Pharmaceuticals, Inc. [read post]
28 Sep 2012, 11:15 am
Watson Pharmaceuticals, Inc., No. 10-12729, where the Eleventh Circuit upheld reverse payments -- finding no antitrust violation in settlements involving generic Androgel. [read post]
16 Sep 2012, 5:12 pm
Watson Pharmaceuticals, Inc., 677 F.3d 1298 (11th Cir. 2012). [read post]
4 Sep 2012, 7:04 am
Watson Pharmaceuticals, Inc., No. 10-12729 (11th Cir. [read post]
15 Aug 2012, 11:02 am
According to Watson, “[b]ased on the simultaneous filing of the Watson ANDA with Mylan and Ranbaxy’s ANDAs, Watson has expected to share the period of 180-day exclusivity with Mylan and Ranbaxy (as well as with a fourth generic manufacturer, Teva Pharmaceuticals (‘Teva’), that has been granted a license by Takeda). [read post]
5 Aug 2012, 7:54 pm
• Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc.; Watson Pharma Inc. [read post]
18 Jul 2012, 5:20 am
Watson Pharmaceuticals, Inc. [read post]
